secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001193125-24-083568
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex raises ~$4.5M via multiple equity financings; issues Series A Preferred and warrants
--------------------------------------------------------------------------------

- Gross proceeds: ~$1.5M from RDO + PIPE (193K shares and warrants at $7.77/unit).
- Additional Private Placement: ~$1.25M from 159,683 shares and warrants at $7.77/unit; insiders participated.
- ADDF Transaction: $1.75M from Series A Preferred (5% cumulative dividend, convertible) and warrants for 229,057 shares.
- Warrants exercisable at $7.64/share, 5-year term; callable after positive SIGNAL-AD Alzheimer's data release.
- Lock-up on insiders through May 12, 2024; company restricted from most equity issuances until June 26, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524083568/0001193125-24-083568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524083568/d801492d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-083568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer